Table 5.
Incremental cost-effectiveness lung cancer screening by National Lung Screening Trial subgroup
| Characteristics | Number of participants | Incremental costs (U.S. $) | Incremental QALYs | Cost per QALY (U.S. $) | |
|---|---|---|---|---|---|
| Sex | Male | 31,446 | 1,683 | 0.0115 | 147,000 |
| Female | 21,856 | 1,557 | 0.0340 | 46,000 | |
| Age at entry | 55–59 | 22,773 | 1,541 | 0.0101 | 152,000 |
| 60–64 | 16,333 | 1,520 | 0.0320 | 48,000 | |
| 65–69 | 9,504 | 1,900 | 0.0351 | 54,000 | |
| 70–74 | 4,685 | 1,905 | 0.0163 | 117,000 | |
| Smoking status | Former | 27,643 | 1,661 | 0.0027 | 615,000 |
| Current | 25,659 | 1,601 | 0.0369 | 43,000 | |
| Risk of lung cancer | First quintile | 10,660 | 1,453 | 0.0086 | 169,000 |
| Second quintile | 10,661 | 1,454 | 0.0118 | 123,000 | |
| Third quintile | 10,660 | 1,651 | 0.0061 | 269,000 | |
| Fourth quintile | 10,661 | 1,672 | 0.0515 | 32,000 | |
| Fifth quintile | 10,660 | 1,851 | 0.0354 | 52,000 | |
Abbreviations: QALY = quality-adjusted life year
Data from Black WC, et al. New Engl J Med 2014:371:1793